Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles
https://pixabay.com/en/technology-robot-human-hand-2025795/

Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles

Many medical professionals have applauded artificial intelligence and machine learning in the drug development process for a long time, as they can increase the speed while decreasing the cost. However,…

Continue Reading Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles

ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols

According to a recent publication from BioPharma Dive, Dr. Janet Woodcock sat for an interview at the Biotechnology Innovation Organization's annual conference in Philadelphia earlier this month. Woodcock, the Director…

Continue Reading ICYMI: Director of FDA’s Center for Drug Evaluation Discusses Accelerated Approval, Benefits of Master Protocols